Login / Signup

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting.

Martina BurlandoRiccardo CastelliEmanuele CozzaniAurora Parodi
Published in: Drugs in context (2021)
Our experience in the real-life setting confirms the efficacy and safety of tildrakizumab as demonstrated by clinical trials.
Keyphrases
  • clinical trial
  • coronary artery disease
  • high intensity
  • early onset
  • randomized controlled trial
  • combination therapy
  • open label
  • phase ii
  • study protocol
  • smoking cessation